Time in Range Coalition
Everyone with diabetes deserves to have the tools, therapies, and technologies to live their best life. The diaTribe Foundation formed The Time in Range Coalition with a multi-stakeholder group of companies, foundations, non-profit organizations, researchers, and clinicians.
Our goal is to establish time in range as an essential part of diabetes care and to make time in range (TIR) accessible to all people with diabetes and their care teams. This involves work in multiple areas, including regulatory, clinical, research, and patient education.
We are grateful for the support of all Time in Range Coalition members.
Time in Range Coalition Overall Objective: Ensure that TIR becomes the primary glucose metric for daily management, complemented by A1C, in diabetes care globally.
To achieve this objective, the Time in Range Coalition focuses its efforts in three priority areas, including:
People with Diabetes
Regulatory & Policy
The following objectives direct the work in each of these areas (also called work streams), and the Time in Range Coalition’s 2021 efforts are guided by the following goals.
People with Diabetes (PWD)
Objective: Ensure that TIR becomes the primary glucose metric for daily diabetes management, complemented by A1C, for all people with diabetes across the globe, by:
increasing awareness of TIR to motivate PWD to accept, embrace, and make changes in their diabetes care;
educating PWD about the impact of using TIR to make treatment and lifestyle decisions, improve daily quality of life and outcomes, including hyperglycemia and hypoglycemia, and to reduce short-term and long-term health complications; and
increasing PWD’s knowledge of and access to TIR data to empower them to discuss the benefits of monitoring TIR with their health care team.
2021 Goal: Map baseline levels of awareness, value, and use of TIR through global market research, develop simplified messaging for a digital campaign for target audiences to increase awareness of TIR, establish metrics to measure the success of the campaign, and launch a digital campaign (with a primary focus in the U.S.).
Healthcare Professionals (HCPs)
Objectives: Ensure that TIR becomes the primary glucose metric for daily diabetes management and treatment decisions, complemented by A1C, across the globe, by:
enhancing HCPs’ understanding of glucose metrics (A1C, CGM metrics, and alternative markers of glucose control) through the insights provided by TIR.;
supporting improvements in office workflow to increase HCPs’ comfort and effectiveness in prescribing, using, and educating patients on therapies and technology available to measure and improve TIR; and
driving integration and consistency in existing practice guidelines to promote the incorporation of TIR into clinical diabetes management.
2021 Goal: Map baseline levels of awareness, value, and use of TIR through global market research, develop simplified messaging for a digital campaign for target audiences to increase awareness of TIR, establish metrics to measure the success of the campaign, and launch a digital campaign (with a primary focus in the U.S.). Identify the inconsistencies and gaps in existing practice guidelines documents globally, and determine the strategy for addressing them.
Regulatory & Policy
Objectives: Establish TIR (as well as TAR and TBR) as a clinically meaningful endpoint in clinical trials and for use in product labeling by:
increasing awareness of TIR and its implications for PWD to global regulatory agencies;
reducing barriers to diabetes technology access for all people with diabetes;
engaging with researchers to increase clinical and patient-reported evidence supporting TIR as a clinically meaningful endpoint; and
collaborating with already established initiatives.
2021 Goal: Identify barriers to integrating TIR as an accepted metric among regulators and create a strategy to address those barriers with the FDA and EMA.
Executive Steering Committee Members
Steering Committee Members